ABBV:NYE-AbbVie Inc.

EQUITY | Drug Manufacturers | New York Stock Exchange

Last Closing

USD 78.69

Change

0.00 (0.00)%

Market Cap

USD 96.34B

Volume

4.08M

Analyst Target

USD 89.73
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

AbbVie Inc is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture and sale of a broad line of pharmaceutical products for treating chronic autoimmune diseases, virology and neurological disorders.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2019-06-16 )

Largest Industry Peers for Drug Manufacturers

Symbol Name Price(Change) Market Cap
SSO ProShares Ultra S&P500

+2.46 (+1.93%)

USD 2.40B
QLD ProShares Ultra QQQ

+2.44 (+2.47%)

USD 1.90B
UYG ProShares Ultra Financials

+0.95 (+2.06%)

USD 0.80B
PSQ ProShares Short QQQ

-0.34 (-1.24%)

USD 0.50B
DDM ProShares Ultra Dow30

+0.90 (+1.84%)

USD 0.36B
DOG ProShares Short Dow30

-0.47 (-0.89%)

USD 0.22B
UWM ProShares Ultra Russell2000

+1.51 (+2.40%)

USD 0.17B
DXD ProShares UltraShort Dow30

-0.47 (-1.82%)

USD 0.16B
MVV ProShares Ultra MidCap400

+0.61 (+1.57%)

USD 0.14B
URE ProShares Ultra Real Estate

+0.18 (+0.21%)

USD 0.14B

ETFs Containing ABBV

WBIL WBI BullBear Quality 1000.. 0.00 % 1.07 %

+0.12 (+1.00%)

USD 0.06B
WBIE WBI BullBear Rising Incom.. 0.00 % 1.05 %

+0.17 (+1.00%)

USD 0.06B
XBI SPDR S&P Biotech ETF 0.00 % 0.35 %

+1.92 (+1.00%)

USD 4.48B
XLV Health Care Select Sector.. 0.00 % 0.13 %

+1.64 (+1.00%)

USD 18.43B
ZDY:CA BMO US Dividend ETF (CAD) 0.00 % 0.32 %

+0.18 (+1.00%)

CAD 1.33B
ZDY.U:CA 0.00 % 0.33 %

N/A

N/A
VHT Vanguard Health Care Inde.. 0.00 % 0.10 %

+3.05 (+1.00%)

USD 9.24B
SPYD SPDR Portfolio S&P 50.. 0.00 % 0.08 %

+0.26 (+1.00%)

USD 1.68B
SDOG ALPS Sector Dividend Dogs.. 0.00 % 0.40 %

+0.39 (+1.00%)

USD 1.83B
RYH Invesco S&P 500 Equal Wei.. 0.00 % 0.40 %

+2.84 (+1.00%)

USD 0.76B
SDY SPDR S&P Dividend ETF 0.00 % 0.35 %

+0.57 (+1.00%)

USD 18.74B
SDYL UBS ETRACS Monthly Pay 2x.. 0.00 % 0.00 %

+1.08 (+1.00%)

USD 0.02B
SICK 0.00 % 0.95 %

N/A

N/A
ZWH.U:CA 0.00 % 0.72 %

N/A

N/A
ZWH:CA BMO US High Dividend Cove.. 0.00 % 0.71 %

+0.08 (+1.00%)

CAD 0.75B
RNDV First Trust US Equity Div.. 0.00 % 0.50 %

N/A

USD 5.46M
MPCT 0.00 % 0.49 %

N/A

N/A
ACT AdvisorShares Vice ETF 0.00 % 0.75 %

+0.18 (+1.00%)

USD 0.01B
SDG iShares MSCI Global Impac.. 0.00 % 0.49 %

+0.28 (+1.00%)

USD 0.05B
DQML Reality Shares Fundstrat .. 0.00 % 0.00 %

+0.26 (+1.00%)

USD 2.62M
FTXH First Trust Nasdaq Pharma.. 0.00 % 0.60 %

+0.44 (+1.00%)

USD 7.40M
SPDV AAM S&P 500 High Dividend.. 0.00 % 0.29 %

+0.28 (+1.00%)

USD 0.03B
HHL.U:CA 0.00 % 1.15 %

N/A

N/A
HHL:CA Harvest Healthcare Leader.. 0.00 % 1.15 %

+0.12 (+1.00%)

CAD 0.33B
CAPS:CA Evolve Active US Core Equ.. 0.00 % 0.96 %

N/A

CAD 3.62M
WBIY WBI Power Factor High Div.. 0.00 % 0.70 %

+0.27 (+1.00%)

USD 0.10B
GIGB Goldman Sachs ETF Trust -.. 0.00 % 0.14 %

-0.10 (1.00%)

USD 0.46B
RXL ProShares Ultra Health Ca.. 0.00 % 0.95 %

+3.39 (+1.00%)

USD 0.11B
RXD ProShares UltraShort Heal.. 0.00 % 0.95 %

-0.79 (1.00%)

USD 2.38M
FDL First Trust Morningstar D.. 0.00 % 0.45 %

+0.33 (+1.00%)

USD 1.66B
ESGW Columbia Sustainable Glob.. 0.00 % 0.40 %

+0.27 (+1.00%)

USD 0.02B
FHLC Fidelity MSCI Health Care.. 0.00 % 0.08 %

+0.82 (+1.00%)

USD 1.58B
FLAG FLAG-Forensic Accounting .. 0.00 % 1.52 %

+0.28 (+1.00%)

USD 9.52M
IBDL iShares iBonds Dec 2020 T.. 0.00 % 0.10 %

-0.01 (1.00%)

USD 1.15B
GSY Invesco Ultra Short Durat.. 0.00 % 0.25 %

N/A

USD 2.39B
ESGS Columbia Sustainable U.S... 0.00 % 0.35 %

+0.28 (+1.00%)

USD 5.55M
EQWL Invesco S&P 100 Equal Wei.. 0.00 % 0.25 %

+0.56 (+1.00%)

USD 0.06B
CUD:CA iShares US Dividend Growe.. 0.00 % 0.66 %

-0.11 (1.00%)

CAD 0.54B
BSCP Invesco BulletShares 2025.. 0.00 % 0.10 %

-0.06 (1.00%)

USD 0.29B
CUD.A:CA 0.00 % 1.48 %

N/A

N/A
DGRO iShares Core Dividend Gro.. 0.00 % 0.08 %

+0.33 (+1.00%)

USD 7.71B
DGRW WisdomTree U.S. Quality D.. 0.00 % 0.28 %

+0.35 (+1.00%)

USD 2.69B
IBDN iShares iBonds Dec 2022 T.. 0.00 % 0.10 %

-0.02 (1.00%)

USD 0.88B
IBDQ iShares iBonds Dec 2025 T.. 0.00 % 0.10 %

-0.06 (1.00%)

USD 0.45B
PPH VanEck Vectors Pharmaceut.. 0.00 % 0.36 %

+0.73 (+1.00%)

USD 0.18B
PKW Invesco BuyBack Achievers.. 0.00 % 0.62 %

+0.55 (+1.00%)

USD 1.16B
QVM Arrow QVM Equity Factor E.. 0.00 % 0.65 %

+0.27 (+1.00%)

USD 4.10M
RDIV Invesco S&P Ultra Dividen.. 0.00 % 0.39 %

+0.25 (+1.00%)

USD 1.78B
RXD ProShares UltraShort Heal.. 0.00 % 0.77 %

-0.79 (1.00%)

USD 2.38M
PJP Invesco Dynamic Pharmaceu.. 0.00 % 0.56 %

+0.81 (+1.00%)

USD 0.39B
PILL Direxion Daily Pharmaceut.. 0.00 % 0.98 %

+1.44 (+1.00%)

USD 0.01B
LABU Direxion Daily S&P Biotec.. 0.00 % 1.14 %

+2.25 (+1.00%)

USD 0.65B
IYH iShares U.S. Healthcare E.. 0.00 % 0.43 %

+3.19 (+1.00%)

USD 2.16B
LABD Direxion Daily S&P Biotec.. 0.00 % 1.00 %

-1.77 (1.00%)

USD 0.08B
NOBL 0.00 % 0.35 %

N/A

N/A
NUAG Nuveen Enhanced Yield U.S.. 0.00 % 0.20 %

N/A

USD 0.07B
BSCK Invesco BulletShares 2020.. 0.00 % 0.10 %

-0.02 (1.00%)

USD 1.77B

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -14.64% 19% F 7% F
Dividend Return 2.32% 82% B- 66% D
Total Return -12.32% 19% F 8% F
Trailing 12 Months  
Capital Gain -20.97% 43% F 19% F
Dividend Return 4.08% 83% B 61% D-
Total Return -16.89% 38% F 21% F
Trailing 5 Years  
Capital Gain 45.72% 88% B+ 81% B-
Dividend Return 24.87% 100% A+ 74% C
Total Return 70.59% 88% B+ 84% B
Average Annual (5 Year Horizon)  
Capital Gain 12.55% 86% B 86% B
Dividend Return 16.37% 90% A- 87% B+
Total Return 3.82% 87% B+ 66% D
Risk Return Profile  
Volatility (Standard Deviation) 27.84% 29% F 20% F
Risk Adjusted Return 58.81% 81% B- 66% D
Market Capitalization 96.34B 85% B 99% A+

Key Financial Ratios

  Ratio vs. Industry/Classification (Drug Manufacturers) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 16.30 41% F 29% F
Price/Book Ratio -39.74 100% A+ 99% A+
Price / Cash Flow Ratio 2.31 52% F 52% F
Price/Free Cash Flow Ratio 9.32 67% D+ 54% F
Management Effectiveness  
Return on Equity -203.31% 4% F 1% F
Return on Invested Capital 20.96% 81% B- 85% B
Return on Assets 8.87% 81% B- 85% B
Debt to Equity Ratio -478.75% 100% A+ 98% A+

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Negative Book Value

The company has negative book value.